Heron Other Liab from 2010 to 2024

HRTX Stock  USD 1.19  0.03  2.59%   
Heron Therapeuti Other Liabilities yearly trend continues to be fairly stable with very little volatility. Other Liabilities will likely drop to about 263.3 K in 2024. During the period from 2010 to 2024, Heron Therapeuti Other Liabilities regression line of annual values had r-squared of  0.44 and arithmetic mean of  20,190,696. View All Fundamentals
 
Other Liabilities  
First Reported
2000-03-31
Previous Quarter
241 K
Current Value
241 K
Quarterly Volatility
11.5 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Heron Therapeuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heron Therapeuti's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3 M, Interest Expense of 4.1 M or Total Revenue of 133.4 M, as well as many indicators such as Price To Sales Ratio of 1.76, Dividend Yield of 0.0 or Days Sales Outstanding of 110. Heron financial statements analysis is a perfect complement when working with Heron Therapeuti Valuation or Volatility modules.
  
Check out the analysis of Heron Therapeuti Correlation against competitors.
For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.

Latest Heron Therapeuti's Other Liab Growth Pattern

Below is the plot of the Other Liab of Heron Therapeuti over the last few years. It is Heron Therapeuti's Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heron Therapeuti's overall financial position and show how it may be relating to other accounts over time.
Other Liab10 Years Trend
Slightly volatile
   Other Liab   
       Timeline  

Heron Other Liab Regression Statistics

Arithmetic Mean20,190,696
Geometric Mean2,252,713
Coefficient Of Variation124.78
Mean Deviation23,847,443
Median277,150
Standard Deviation25,193,955
Sample Variance634.7T
Range49.8M
R-Value(0.67)
Mean Square Error381.3T
R-Squared0.44
Significance0.01
Slope(3,746,418)
Total Sum of Squares8886.3T

Heron Other Liab History

2024263.3 K
2023277.1 K
2017241 K
201150 M
2010874 K

About Heron Therapeuti Financial Statements

Heron Therapeuti investors use historical fundamental indicators, such as Heron Therapeuti's Other Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Heron Therapeuti. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Liabilities277.1 K263.3 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Heron Stock Analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.